FFA
TARS icon

Farther Finance Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History

Farther Finance Advisors’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$46.4K Buy
590
+528
+852% +$36.7K ﹤0.01% 3485
2026
Q2 		$3.9K Buy
62
+38
+158% +$2.43K ﹤0.01% 4917
2026
Q1 		$1.69K Buy
24
+1
+4% +$70 ﹤0.01% 4953
2025
Q4 		$1.88K Buy
23
+1
+5% +$75 ﹤0.01% 4716
2025
Q3 		$1.31K Buy
22
+10
+83% +$492 ﹤0.01% 4284
2025
Q2 		$486 Hold
12
– – ﹤0.01% 4044
2025
Q1 		$587 Hold
12
– – ﹤0.01% 3747
2024
Q4 		$664 Hold
12
– – ﹤0.01% 3376
2024
Q3 		$395 Hold
12
– – ﹤0.01% 3476
2024
Q2 		$339 Hold
12
– – ﹤0.01% 3367
2024
Q1 		$430 Hold
12
– – ﹤0.01% 3062
2023
Q4 		$243 Buy
+12
New +$200 ﹤0.01% 3182

Other funds holding TARS

VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors's TARS Position: Q3 2026 in Review

Farther Finance Advisors increased its Tarsus Pharmaceuticals (TARS) stake by 852% in Q3 2026, buying an estimated $36.7K and bringing the position to 590 shares worth $46.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3485.

Farther Finance Advisors first reported a position in TARS in Q4 2023 and has held it in 12 quarters since. 5 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • Farther Finance Advisors held 590 shares of Tarsus Pharmaceuticals worth $46.4K as of Q3 2026.
  • Farther Finance Advisors bought 528 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $36.7K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3485 holding.
  • Farther Finance Advisors first reported a position in Tarsus Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • 5 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.